Press Releases Jun 22, 2018 • 8:30 AM EDT Matinas BioPharma Announces Closing of $8.0 Million Public Offering Jun 19, 2018 • 8:00 AM EDT Matinas BioPharma Announces Pricing of $8.0 Million Public Offering Jun 12, 2018 • 8:00 AM EDT Matinas BioPharma to Present at the 20th ICHS Symposium on Infections in the Immunocompromised Host Jun 6, 2018 • 7:35 AM EDT Matinas BioPharma to Present Preclinical Data at ASM Microbe 2018 Further Demonstrating the Broad Utility of its LNC Platform May 10, 2018 • 7:05 AM EDT Matinas BioPharma Reports First Quarter 2018 Financial Results and Provides Corporate Update May 7, 2018 • 8:05 AM EDT Matinas BioPharma to Host Quarterly Update Conference Call May 1, 2018 • 8:05 AM EDT Matinas BioPharma Selected to Present at the BioNJ Eighth Annual BioPartnering Conference Apr 19, 2018 • 8:05 AM EDT Matinas BioPharma to Present Positive Preclinical Data of MAT2203 at the 28th European Congress of Clinical Microbiology and Infectious Disease Mar 26, 2018 • 4:45 PM EDT Matinas BioPharma Reports 2017 Financial Results Mar 16, 2018 • 5:00 PM EDT Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer and Provides Corporate Update << Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ...17 | Next >>
